<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2025//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_250101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">40984984</PMID><DateCompleted><Year>2025</Year><Month>09</Month><Day>23</Day></DateCompleted><DateRevised><Year>2025</Year><Month>09</Month><Day>25</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">2634-3916</ISSN><JournalIssue CitedMedium="Internet"><Volume>6</Volume><Issue>5</Issue><PubDate><Year>2025</Year><Month>Sep</Month></PubDate></JournalIssue><Title>European heart journal. Digital health</Title><ISOAbbreviation>Eur Heart J Digit Health</ISOAbbreviation></Journal><ArticleTitle>Cost-effectiveness of a clinical decision support system for atrial fibrillation: an RCT-based modelling study.</ArticleTitle><Pagination><StartPage>997</StartPage><EndPage>1005</EndPage><MedlinePgn>997-1005</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1093/ehjdh/ztaf087</ELocationID><Abstract><AbstractText Label="AIMS" NlmCategory="UNASSIGNED">Atrial fibrillation (AF) is a common arrythmia that increases the risk of thromboembolism. Despite the effectiveness of anticoagulation in AF, underuse remains a substantial problem. Clinical decision support (CDS) systems may increase adherence to guideline recommended anticoagulation in AF. However, evidence regarding the cost-effectiveness of these interventions is lacking. The aim of this study was therefore to evaluate the cost-effectiveness of a CDS for AF.</AbstractText><AbstractText Label="METHODS AND RESULTS" NlmCategory="UNASSIGNED">We developed a disease progression model with a Markov structure and simulated a cohort of hypothetical individuals with AF through a standard of care and a CDS strategy. The adherence to anticoagulation in the model was based on the treatment effect reported in the CDS-AF trial, which evaluated the effect of a CDS in patients with AF in the primary care in &#xd6;sterg&#xf6;tland, Sweden. The cost-effectiveness of the CDS-AF intervention compared with standard of care was determined by estimating costs and quality-adjusted life years (QALYs) gained over a lifetime time horizon and was reported as an incremental cost-effectiveness ratio (ICER) assessed against a decision-threshold of &#x20ac;50 000. Uncertainty was evaluated using both one-way and probabilistic sensitivity analysis (PSA). The CDS-intervention resulted in fewer ischaemic strokes but more bleedings. The mean per patient gain in QALYs was 0.012 and the ICER was &#x20ac;963 per QALY gained. The result of the PSA indicated a high probability that the ICER was below &#x20ac;50 000.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="UNASSIGNED">The CDS intervention used in the CDS-AF trial appears to yield health gains at a lower cost than typically considered cost-effective.</AbstractText><AbstractText Label="TRIAL REGISTRATION" NlmCategory="UNASSIGNED">NCT02635685.</AbstractText><CopyrightInformation>&#xa9; The Author(s) 2025. Published by Oxford University Press on behalf of the European Society of Cardiology.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Persson Lindell</LastName><ForeName>Olof</ForeName><Initials>O</Initials><Identifier Source="ORCID">0000-0002-3705-1587</Identifier><AffiliationInfo><Affiliation>Department of Cardiology, Link&#xf6;ping University Hospital, Kardiologiska Kliniken, Universitetssjukhuset, Link&#xf6;ping 581 85, Sweden.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Health, Medicine and Caring Sciences, Link&#xf6;ping University, Link&#xf6;ping, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Henriksson</LastName><ForeName>Martin</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0003-1699-3185</Identifier><AffiliationInfo><Affiliation>Department of Health, Medicine and Caring Sciences, Center for Medical Technology Assessment, Link&#xf6;ping University, Link&#xf6;ping, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Karlsson</LastName><ForeName>Lars O</ForeName><Initials>LO</Initials><Identifier Source="ORCID">0000-0003-4852-3065</Identifier><AffiliationInfo><Affiliation>Department of Cardiology, Link&#xf6;ping University Hospital, Kardiologiska Kliniken, Universitetssjukhuset, Link&#xf6;ping 581 85, Sweden.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Health, Medicine and Caring Sciences, Link&#xf6;ping University, Link&#xf6;ping, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nilsson</LastName><ForeName>Staffan</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Health, Medicine and Caring Sciences, Link&#xf6;ping University, Link&#xf6;ping, Sweden.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Division of Primary Health Care of Region &#xd6;sterg&#xf6;tland, Link&#xf6;ping, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Charitakis</LastName><ForeName>Emmanouil</ForeName><Initials>E</Initials><Identifier Source="ORCID">0000-0002-2514-5324</Identifier><AffiliationInfo><Affiliation>Department of Cardiology, Link&#xf6;ping University Hospital, Kardiologiska Kliniken, Universitetssjukhuset, Link&#xf6;ping 581 85, Sweden.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Health, Medicine and Caring Sciences, Link&#xf6;ping University, Link&#xf6;ping, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Janzon</LastName><ForeName>Magnus</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0002-9375-5087</Identifier><AffiliationInfo><Affiliation>Department of Cardiology, Link&#xf6;ping University Hospital, Kardiologiska Kliniken, Universitetssjukhuset, Link&#xf6;ping 581 85, Sweden.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Health, Medicine and Caring Sciences, Link&#xf6;ping University, Link&#xf6;ping, Sweden.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><DataBankList CompleteYN="Y"><DataBank><DataBankName>ClinicalTrials.gov</DataBankName><AccessionNumberList><AccessionNumber>NCT02635685</AccessionNumber></AccessionNumberList></DataBank></DataBankList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2025</Year><Month>08</Month><Day>01</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Eur Heart J Digit Health</MedlineTA><NlmUniqueID>101778323</NlmUniqueID><ISSNLinking>2634-3916</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Atrial fibrillation</Keyword><Keyword MajorTopicYN="N">Clinical decision support</Keyword><Keyword MajorTopicYN="N">Cost-effectiveness</Keyword><Keyword MajorTopicYN="N">Electronic health record</Keyword><Keyword MajorTopicYN="N">Health care economics</Keyword></KeywordList><CoiStatement>Conflict of interest: none declared.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2025</Year><Month>5</Month><Day>2</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2025</Year><Month>6</Month><Day>10</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2025</Year><Month>6</Month><Day>30</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2025</Year><Month>9</Month><Day>23</Day><Hour>6</Hour><Minute>38</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2025</Year><Month>9</Month><Day>23</Day><Hour>6</Hour><Minute>37</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2025</Year><Month>9</Month><Day>23</Day><Hour>3</Hour><Minute>54</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2025</Year><Month>8</Month><Day>1</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">40984984</ArticleId><ArticleId IdType="pmc">PMC12450513</ArticleId><ArticleId IdType="doi">10.1093/ehjdh/ztaf087</ArticleId><ArticleId IdType="pii">ztaf087</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Van Gelder &#xa0;IC, Rienstra &#xa0;M, Bunting &#xa0;KV, Casado-Arroyo &#xa0;R, Caso &#xa0;V, Crijns &#xa0;HJGM, et al. &#xa0;2024 ESC guidelines for the management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS). Eur Heart J &#xa0;2024;45:3314&#x2013;3414.</Citation><ArticleIdList><ArticleId IdType="pubmed">39210723</ArticleId></ArticleIdList></Reference><Reference><Citation>Zoni-Berisso &#xa0;M, Lercari &#xa0;F, Carazza &#xa0;T, Domenicucci &#xa0;S. Epidemiology of atrial fibrillation: European perspective. Clin Epidemiol &#xa0;2014;6:213&#x2013;220.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4064952</ArticleId><ArticleId IdType="pubmed">24966695</ArticleId></ArticleIdList></Reference><Reference><Citation>Alkhouli &#xa0;M, Noseworthy &#xa0;PA, Rihal &#xa0;CS, Holmes &#xa0;DR &#xa0;Jr. Stroke prevention in nonvalvular atrial fibrillation: a stakeholder perspective. J Am Coll Cardiol &#xa0;2018;71:2790&#x2013;2801.</Citation><ArticleIdList><ArticleId IdType="pubmed">29903352</ArticleId></ArticleIdList></Reference><Reference><Citation>Andrade &#xa0;J, Khairy &#xa0;P, Dobrev &#xa0;D, Nattel &#xa0;S. The clinical profile and pathophysiology of atrial fibrillation: relationships among clinical features, epidemiology, and mechanisms. Circ Res &#xa0;2014;114:1453&#x2013;1468.</Citation><ArticleIdList><ArticleId IdType="pubmed">24763464</ArticleId></ArticleIdList></Reference><Reference><Citation>Luengo-Fernandez &#xa0;R, Violato &#xa0;M, Candio &#xa0;P, Leal &#xa0;J. Economic burden of stroke across Europe: a population-based cost analysis. Eur Stroke J &#xa0;2020;5:17&#x2013;25.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7092742</ArticleId><ArticleId IdType="pubmed">32232166</ArticleId></ArticleIdList></Reference><Reference><Citation>Hart &#xa0;RG, Pearce &#xa0;LA, Aguilar &#xa0;MI. Meta-analysis: antithrombotic therapy to prevent stroke in patients who have nonvalvular atrial fibrillation. Ann Intern Med &#xa0;2007;146:857&#x2013;867.</Citation><ArticleIdList><ArticleId IdType="pubmed">17577005</ArticleId></ArticleIdList></Reference><Reference><Citation>Ruff &#xa0;CT, Giugliano &#xa0;RP, Braunwald &#xa0;E, Hoffman &#xa0;EB, Deenadayalu &#xa0;N, Ezekowitz &#xa0;MD, et al. &#xa0;Comparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation: a meta-analysis of randomised trials. Lancet &#xa0;2014;383:955&#x2013;962.</Citation><ArticleIdList><ArticleId IdType="pubmed">24315724</ArticleId></ArticleIdList></Reference><Reference><Citation>Bruins Slot &#xa0;KMH, Berge &#xa0;E. Factor Xa inhibitors versus vitamin K antagonists for preventing cerebral or systemic embolism in patients with atrial fibrillation. Cochrane Database Syst Rev &#xa0;2018;3:CD008980.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6494202</ArticleId><ArticleId IdType="pubmed">29509959</ArticleId></ArticleIdList></Reference><Reference><Citation>Hindricks &#xa0;G, Potpara &#xa0;T, Dagres &#xa0;N, Arbelo &#xa0;E, Bax &#xa0;JJ, Blomstrom-Lundqvist &#xa0;C, et al. &#xa0;2020 ESC guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS): the task force for the diagnosis and management of atrial fibrillation of the European Society of Cardiology (ESC) developed with the special contribution of the European Heart Rhythm Association (EHRA) of the ESC. Eur Heart J &#xa0;2021;42:373&#x2013;498.</Citation><ArticleIdList><ArticleId IdType="pubmed">32860505</ArticleId></ArticleIdList></Reference><Reference><Citation>Mazurek &#xa0;M, Shantsila &#xa0;E, Lane &#xa0;DA, Wolff &#xa0;A, Proietti &#xa0;M, Lip &#xa0;GYH. Secondary versus primary stroke prevention in atrial fibrillation: insights from the darlington atrial fibrillation registry. Stroke &#xa0;2017;48:2198&#x2013;2205.</Citation><ArticleIdList><ArticleId IdType="pubmed">28679859</ArticleId></ArticleIdList></Reference><Reference><Citation>Lowres &#xa0;N, Giskes &#xa0;K, Hespe &#xa0;C, Freedman &#xa0;B. Reducing stroke risk in atrial fibrillation: adherence to guidelines has improved, but patient persistence with anticoagulant therapy remains suboptimal. Korean Circ J &#xa0;2019;49:883&#x2013;907.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6753021</ArticleId><ArticleId IdType="pubmed">31535493</ArticleId></ArticleIdList></Reference><Reference><Citation>Navar &#xa0;AM, Kolkailah &#xa0;AA, Overton &#xa0;R, Shah &#xa0;NP, Rousseau &#xa0;JF, Flaker &#xa0;GC, et al. &#xa0;Trends in oral anticoagulant use among 436 864 patients with atrial fibrillation in community practice, 2011 to 2020. J Am Heart Assoc &#xa0;2022;11:e026723.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9750070</ArticleId><ArticleId IdType="pubmed">36346063</ArticleId></ArticleIdList></Reference><Reference><Citation>Bright &#xa0;TJ, Wong &#xa0;A, Dhurjati &#xa0;R, Bristow &#xa0;E, Bastian &#xa0;L, Coeytaux &#xa0;RR, et al. &#xa0;Effect of clinical decision-support systems: a systematic review. Ann Intern Med &#xa0;2012;157:29&#x2013;43.</Citation><ArticleIdList><ArticleId IdType="pubmed">22751758</ArticleId></ArticleIdList></Reference><Reference><Citation>Moja &#xa0;L, Kwag &#xa0;KH, Lytras &#xa0;T, Bertizzolo &#xa0;L, Brandt &#xa0;L, Pecoraro &#xa0;V, et al. &#xa0;Effectiveness of computerized decision support systems linked to electronic health records: a systematic review and meta-analysis. Am J Public Health &#xa0;2014;104:e12&#x2013;e22.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4232126</ArticleId><ArticleId IdType="pubmed">25322302</ArticleId></ArticleIdList></Reference><Reference><Citation>Jaspers &#xa0;MW, Smeulers &#xa0;M, Vermeulen &#xa0;H, Peute &#xa0;LW. Effects of clinical decision-support systems on practitioner performance and patient outcomes: a synthesis of high-quality systematic review findings. J Am Med Inform Assoc &#xa0;2011;18:327&#x2013;334.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3078663</ArticleId><ArticleId IdType="pubmed">21422100</ArticleId></ArticleIdList></Reference><Reference><Citation>Sutton &#xa0;RT, Pincock &#xa0;D, Baumgart &#xa0;DC, Sadowski &#xa0;DC, Fedorak &#xa0;RN, Kroeker &#xa0;KI. An overview of clinical decision support systems: benefits, risks, and strategies for success. NPJ Digit Med &#xa0;2020;3:17.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7005290</ArticleId><ArticleId IdType="pubmed">32047862</ArticleId></ArticleIdList></Reference><Reference><Citation>Varghese &#xa0;J, Kleine &#xa0;M, Gessner &#xa0;SI, Sandmann &#xa0;S, Dugas &#xa0;M. Effects of computerized decision support system implementations on patient outcomes in inpatient care: a systematic review. J Am Med Inform Assoc &#xa0;2018;25:593&#x2013;602.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7646949</ArticleId><ArticleId IdType="pubmed">29036406</ArticleId></ArticleIdList></Reference><Reference><Citation>Lu &#xa0;Y, Melnick &#xa0;ER, Krumholz &#xa0;HM. Clinical decision support in cardiovascular medicine. BMJ &#xa0;2022;377:e059818.</Citation><ArticleIdList><ArticleId IdType="pubmed">35613721</ArticleId></ArticleIdList></Reference><Reference><Citation>Lyell &#xa0;D, Coiera &#xa0;E. Automation bias and verification complexity: a systematic review. J Am Med Inform Assoc &#xa0;2017;24:423&#x2013;431.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7651899</ArticleId><ArticleId IdType="pubmed">27516495</ArticleId></ArticleIdList></Reference><Reference><Citation>Jacob &#xa0;V, Thota &#xa0;AB, Chattopadhyay &#xa0;SK, Njie &#xa0;GJ, Proia &#xa0;KK, Hopkins &#xa0;DP, et al. &#xa0;Cost and economic benefit of clinical decision support systems for cardiovascular disease prevention: a community guide systematic review. J Am Med Inform Assoc &#xa0;2017;24:669&#x2013;676.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5538577</ArticleId><ArticleId IdType="pubmed">28049635</ArticleId></ArticleIdList></Reference><Reference><Citation>Amin &#xa0;AM, Ghaly &#xa0;R, Abuelazm &#xa0;MT, Ibrahim &#xa0;AA, Tanashat &#xa0;M, Arnaout &#xa0;M, et al. &#xa0;Clinical decision support systems to optimize adherence to anticoagulant guidelines in patients with atrial fibrillation: a systematic review and meta-analysis of randomized controlled trials. Thromb J &#xa0;2024;22:45.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC11134712</ArticleId><ArticleId IdType="pubmed">38807186</ArticleId></ArticleIdList></Reference><Reference><Citation>Karlsson &#xa0;LO, Nilsson &#xa0;S, Bang &#xa0;M, Nilsson &#xa0;L, Charitakis &#xa0;E, Janzon &#xa0;M. A clinical decision support tool for improving adherence to guidelines on anticoagulant therapy in patients with atrial fibrillation at risk of stroke: a cluster-randomized trial in a Swedish primary care setting (the CDS-AF study). PLoS Med &#xa0;2018;15:e1002528.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5849292</ArticleId><ArticleId IdType="pubmed">29534063</ArticleId></ArticleIdList></Reference><Reference><Citation>Jones &#xa0;NR, Crawford &#xa0;W, Yang &#xa0;Y, Hobbs &#xa0;FDR, Taylor &#xa0;CJ, Petrou &#xa0;S. A systematic review of economic aspects of service interventions to increase anticoagulation use in atrial fibrillation. Thromb Haemost &#xa0;2022;122:394&#x2013;405.</Citation><ArticleIdList><ArticleId IdType="pubmed">34020487</ArticleId></ArticleIdList></Reference><Reference><Citation>
The Riksbank . Annual and monthly average exchange rates 2024. https://www.riksbank.se/en-gb/statistics/interest-rates-and-exchange-rates/search-annual-and-monthly-average-exchange-rates (5 November 2024).</Citation></Reference><Reference><Citation>Tandv&#xe5;rds- och L&#xe4;kemedelsf&#xf6;rm&#xe5;nsverket (TLV) . L&#xe4;kemedelsf&#xf6;rm&#xe5;nsn&#xe4;mndens allm&#xe4;nna r&#xe5;d om ekonomiska utv&#xe4;rderingar. LFNAR &#xa0;2003;2003:2.</Citation></Reference><Reference><Citation>Tandv&#xe5;rds- och L&#xe4;kemedelsf&#xf6;rm&#xe5;nsverket (TLV) . Underlag f&#xf6;r beslut om subvention&#x2014;Ompr&#xf6;vning. Cerezyme (imiglukeras) och Vpriv (velaglukeras alfa). N&#xe4;mnden f&#xf6;r l&#xe4;kemedelsf&#xf6;rm&#xe5;ner. 2016.</Citation></Reference><Reference><Citation>
R Core Team . R: A Language and Environment for Statistical Computing. R Foundation for Statistical Computing. 2024. https://www.R-project.org/ (11 October 2024).</Citation></Reference><Reference><Citation>Alarid-Escudero &#xa0;F, Krijkamp &#xa0;E, Enns &#xa0;EA, Yang &#xa0;A, Hunink &#xa0;MGM, Pechlivanoglou &#xa0;P, et al. &#xa0;A tutorial on time-dependent cohort state-transition models in R using a cost-effectiveness analysis example. Med Decis Making &#xa0;2023;43:21&#x2013;41.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9844995</ArticleId><ArticleId IdType="pubmed">36112849</ArticleId></ArticleIdList></Reference><Reference><Citation>
OpenAI . ChatGPT [Large language model]. 2024. https://chat.openai.com (9 April 2025).</Citation></Reference><Reference><Citation>
Socialstyrelsen . Statistikdatabas f&#xf6;r l&#xe4;kemedel. 2024. https://www.socialstyrelsen.se/statistik-och-data/statistik/statistikdatabasen/ (26 February 2024).</Citation></Reference><Reference><Citation>Friberg &#xa0;L, Rosenqvist &#xa0;M, Lip &#xa0;GYH. Evaluation of risk stratification schemes for ischaemic stroke and bleeding in 182 678 patients with atrial fibrillation: the Swedish Atrial Fibrillation cohort study. Eur Heart J &#xa0;2012;33:1500&#x2013;1510.</Citation><ArticleIdList><ArticleId IdType="pubmed">22246443</ArticleId></ArticleIdList></Reference><Reference><Citation>Burstr&#xf6;m &#xa0;K, Johannesson &#xa0;M, Diderichsen &#xa0;F. A comparison of individual and social time trade-off values for health states in the general population. Health Policy &#xa0;2006;76:359&#x2013;370.</Citation><ArticleIdList><ArticleId IdType="pubmed">16214258</ArticleId></ArticleIdList></Reference><Reference><Citation>Roalfe &#xa0;AK, Bryant &#xa0;TL, Davies &#xa0;MH, Hackett &#xa0;TG, Saba &#xa0;S, Fletcher &#xa0;K, et al. &#xa0;A cross-sectional study of quality of life in an elderly population (75 years and over) with atrial fibrillation: secondary analysis of data from the Birmingham Atrial Fibrillation Treatment of the Aged study. Europace &#xa0;2012;14:1420&#x2013;1427.</Citation><ArticleIdList><ArticleId IdType="pubmed">22581625</ArticleId></ArticleIdList></Reference><Reference><Citation>Reynolds &#xa0;MR, Lavelle &#xa0;T, Essebag &#xa0;V, Cohen &#xa0;DJ, Zimetbaum &#xa0;P. Influence of age, sex, and atrial fibrillation recurrence on quality of life outcomes in a population of patients with new-onset atrial fibrillation: the Fibrillation Registry Assessing Costs, Therapies, Adverse events and Lifestyle (FRACTAL) study. Am Heart J &#xa0;2006;152:1097&#x2013;1103.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1820843</ArticleId><ArticleId IdType="pubmed">17161061</ArticleId></ArticleIdList></Reference><Reference><Citation>Gage &#xa0;BF, Cardinalli &#xa0;AB, Owens &#xa0;DK. The effect of stroke and stroke prophylaxis with aspirin or warfarin on quality of life. Arch Intern Med &#xa0;1996;156:1829&#x2013;1836.</Citation><ArticleIdList><ArticleId IdType="pubmed">8790077</ArticleId></ArticleIdList></Reference><Reference><Citation>Monz &#xa0;BU, Connolly &#xa0;SJ, Korhonen &#xa0;M, Noack &#xa0;H, Pooley &#xa0;J. Assessing the impact of dabigatran and warfarin on health-related quality of life: results from an RE-LY sub-study. Int J Cardiol &#xa0;2013;168:2540&#x2013;2547.</Citation><ArticleIdList><ArticleId IdType="pubmed">23664436</ArticleId></ArticleIdList></Reference><Reference><Citation>Van Miert &#xa0;JHA, Kooistra &#xa0;HAM, Veeger &#xa0;NJGM, Westerterp &#xa0;A, Piersma-Wichers &#xa0;M, Meijer &#xa0;K. Quality of life after switching from well-controlled vitamin K antagonist to direct oral anticoagulant: little to GAInN. Thromb Res &#xa0;2020;190:69&#x2013;75.</Citation><ArticleIdList><ArticleId IdType="pubmed">32315869</ArticleId></ArticleIdList></Reference><Reference><Citation>
Swedish Confederation of Professional Association . Salery statistics 2023. https://lonesok.saco.se/ (26 March 2024).</Citation></Reference><Reference><Citation>Karlsson &#xa0;LO, Nilsson &#xa0;S, Charitakis &#xa0;E, Bang &#xa0;M, Johansson &#xa0;G, Nilsson &#xa0;L, et al. &#xa0;Clinical decision support for stroke prevention in atrial fibrillation (CDS-AF): rationale and design of a cluster randomized trial in the primary care setting. Am Heart J &#xa0;2017;187:45&#x2013;52.</Citation><ArticleIdList><ArticleId IdType="pubmed">28454807</ArticleId></ArticleIdList></Reference><Reference><Citation>Silbernagel &#xa0;G, Spirk &#xa0;D, Hager &#xa0;A, Baumgartner &#xa0;I, Kucher &#xa0;N. Electronic alert system for improving stroke prevention among hospitalized oral-anticoagulation-naive patients with atrial fibrillation: a randomized trial. J Am Heart Assoc &#xa0;2016;5:e003776.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5015408</ArticleId><ArticleId IdType="pubmed">27451467</ArticleId></ArticleIdList></Reference><Reference><Citation>Hendriks &#xa0;J, Tomini &#xa0;F, Van Asselt &#xa0;T, Crijns &#xa0;H, Vrijhoef &#xa0;H. Cost-effectiveness of a specialized atrial fibrillation clinic vs. usual care in patients with atrial fibrillation. Europace &#xa0;2013;15:1128&#x2013;1135.</Citation><ArticleIdList><ArticleId IdType="pubmed">23515338</ArticleId></ArticleIdList></Reference><Reference><Citation>Blomstrom Lundqvist &#xa0;C, Sjalander &#xa0;S, Garcia Rodriguez &#xa0;LA, Akerborg &#xa0;O, Jin &#xa0;G, Caleyachetty &#xa0;A, et al. &#xa0;Impact of non-adherence to direct oral anticoagulants amongst Swedish patients with non-valvular atrial fibrillation: results from a real-world cost-utility analysis. J Med Econ &#xa0;2022;25:1085&#x2013;1091.</Citation><ArticleIdList><ArticleId IdType="pubmed">35997241</ArticleId></ArticleIdList></Reference><Reference><Citation>Lyth &#xa0;J, Svennberg &#xa0;E, Bernfort &#xa0;L, Aronsson &#xa0;M, Frykman &#xa0;V, Al-Khalili &#xa0;F, et al. &#xa0;Cost-effectiveness of population screening for atrial fibrillation: the STROKESTOP study. Eur Heart J &#xa0;2022;44:196&#x2013;204.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9839418</ArticleId><ArticleId IdType="pubmed">36349968</ArticleId></ArticleIdList></Reference><Reference><Citation>Berner &#xa0;ES, La Lande &#xa0;TJ. Overview of Clinical Decision Support Systems. Cham, Switzerland: Springer International Publishing; 2016. p1&#x2013;17.</Citation></Reference><Reference><Citation>Luscher &#xa0;TF, Wenzl &#xa0;FA, D&#x2019;Ascenzo &#xa0;F, Friedman &#xa0;PA, Antoniades &#xa0;C. Artificial intelligence in cardiovascular medicine: clinical applications. Eur Heart J &#xa0;2024;45:4291&#x2013;4304.</Citation><ArticleIdList><ArticleId IdType="pubmed">39158472</ArticleId></ArticleIdList></Reference><Reference><Citation>Goh &#xa0;B, Bhaskar &#xa0;SMM. The role of artificial intelligence in optimizing management of atrial fibrillation in acute ischemic stroke. Ann N Y Acad Sci &#xa0;2024;1541:24&#x2013;36.</Citation><ArticleIdList><ArticleId IdType="pubmed">39377991</ArticleId></ArticleIdList></Reference><Reference><Citation>Lip &#xa0;GYH, Tran &#xa0;G, Genaidy &#xa0;A, Marroquin &#xa0;P, Estes &#xa0;C, Landsheft &#xa0;J. Improving dynamic stroke risk prediction in non-anticoagulated patients with and without atrial fibrillation: comparing common clinical risk scores and machine learning algorithms. Eur Heart J Qual Care Clin Outcomes &#xa0;2022;8:548&#x2013;556.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9382661</ArticleId><ArticleId IdType="pubmed">33999139</ArticleId></ArticleIdList></Reference><Reference><Citation>Lu &#xa0;J, Hutchens &#xa0;R, Hung &#xa0;J, Bennamoun &#xa0;M, McQuillan &#xa0;B, Briffa &#xa0;T, et al. &#xa0;Performance of multilabel machine learning models and risk stratification schemas for predicting stroke and bleeding risk in patients with non-valvular atrial fibrillation. Comput Biol Med &#xa0;2022;150:106126.</Citation><ArticleIdList><ArticleId IdType="pubmed">36206696</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>